Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-07-19FDA Approved: ONDANSETRON — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's original application for a generic ondansetron hydrochloride product.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Phase II Dose-ranging Study of APD421 in PONV [Phase 2]
Phase II dose-ranging study of APD421 in postoperative nausea and vomiting has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting [Phase 4]
Phase 4 trial update on combining aprepitant with ondansetron to prevent postoperative nausea and vomiting in high-risk patients. The study …
-
FDA approval · 2013-06-30FDA Approved: ONDANSETRON — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves a supplemental application for ondansetron from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. This action suppo…
-
FDA approval · 2013-06-30FDA Approved: ONDANSETRON — Supplemental Application (JVET PHARMACEUTICALS LLC)
FDA approved a supplemental application for ondansetron submitted by JVET PHARMACEUTICALS LLC. This action updates the approval for this gen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-06-29FDA Approved: ONDANSETRON — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for ondansetron submitted by PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2013-04-26FDA Approved: ONDANSETRON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Ondansetron from Sun Pharmaceutical Industries, Inc. (ANDA077557).
-
FDA approval · 2013-04-03FDA Approved: ONDANSETRON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for ondansetron filed by Hikma Pharmaceuticals USA Inc., a supplemental approval for the generic ant…
-
FDA approval · 2013-03-20FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for EMEND (aprepitant) filed by Merck Sharp & Dohme LLC. The action relates to the approved anti…
-
FDA approval · 2013-03-19FDA Approved: ONDANSETRON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for ondansetron from Hikma Pharmaceuticals USA Inc., confirming approval of a generic ondansetron pr…
-
FDA approval · 2013-02-22FDA Approved: ONDANSETRON HYDROCHLORIDE — Original Application (Baxter Healthcare Corporation)
The FDA approved Baxter Healthcare Corporation's original ANDA for ondansetron hydrochloride, enabling a generic version of ondansetron to b…
-
FDA approval · 2013-02-14FDA Approved: GRANISETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Granisetron (granisetron hydrochloride) from Fresenius Kabi USA, LLC.
-
FDA approval · 2012-12-21FDA Approved: ONDANSETRON — Original Application (Eugia US LLC)
FDA approved the original application for ondansetron hydrochloride by Eugia US LLC. The generic drug is indicated to prevent nausea and vom…
-
FDA approval · 2012-12-21FDA Approved: ONDANSETRON — Original Application (Eugia US LLC)
FDA approves Eugia US LLC's original application for ondansetron hydrochloride, granting generic approval for this antiemetic under the ANDA…
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Reduction of Postoperative Pain, Nausea and Vomiting
A completed clinical trial investigating methods to reduce postoperative pain, nausea and vomiting.
-
CLINICAL_TRIALS withdrawal · 2012-10-17Clinical Trial Update: Overnight Use of Electroacustimulation on Postoperative Nausea and Vomiting in the Outpatient Surgery Population [NA]
An outpatient clinical trial evaluating overnight electroacustimulation for postoperative nausea and vomiting has been withdrawn. The study …
-
CLINICAL_TRIALS trial_result · 2012-10-04Clinical Trial Update: A Study to Assess Analgesic Efficacy of Intravenous Lignocaine [Phase 4]
A Phase 4 clinical trial evaluating the analgesic efficacy of intravenous lignocaine for postoperative pain, postoperative nausea and vomiti…
-
CLINICAL_TRIALS research · 2012-10-03Clinical Trial Update: Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery [NA]
This clinical trial update evaluates whether acupuncture can help treat postoperative nausea and vomiting in ambulatory surgery patients. Th…
-
CLINICAL_TRIALS trial_result · 2012-10-02Clinical Trial Update: A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV) [Phase 2]
A Phase 2 clinical trial evaluating vestipitant (GW597599) for breakthrough postoperative nausea and vomiting has completed.
-
FDA approval · 2012-09-24FDA Approved: APREPITANT — Original Application (Sandoz Inc)
The FDA approved Sandoz Inc's original ANDA for aprepitant, a generic NK1 receptor antagonist, for the prevention of chemotherapy-induced na…
-
FDA approval · 2012-09-10FDA Approved: METOCLOPRAMIDE — Supplemental Application (Genus Lifesciences Inc.)
The FDA approved a supplemental application for metoclopramide hydrochloride from Genus Lifesciences Inc., completing regulatory action for …
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy [Phase 4]
This Phase 4 trial evaluated antiemetic prophylaxis to prevent postdischarge nausea and vomiting after hip arthroscopy; results were posted …
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Association of 5-HT3 Receptor Gene Polymorphism With the Efficiency of Ondansetron for Postoperative Nausea and Vomiting [NA]
This completed trial evaluated whether 5-HT3 receptor gene polymorphisms affect the effectiveness of ondansetron for preventing postoperativ…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic Laparoscopy [Phase 2]
A Phase 2 trial evaluating strategies to prevent postoperative nausea and vomiting in patients undergoing ambulatory gynecologic laparoscopy…
-
FDA approval · 2012-06-28FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)
The FDA approved Promethazine hydrochloride as an original generic drug application (ANDA) for Cranbury Pharmaceuticals, LLC.